[
1. Velasquez EJ, Lee KL, Deja MA et al. for the STICH investigators. Coronary artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-1616.10.1056/NEJMoa1100356
]Search in Google Scholar
[
2. Jones RH, Velasques EJ, Michler RE. Coronary bypass surgery with or without ventricular reconstruction. N Engl J Med, 2009;360:1705-1717.10.1056/NEJMoa0900559
]Search in Google Scholar
[
3. Dor V. Left ventricular reconstruction: the aim and the reality after twenty years. J Thorac Cardiovasc Surg 2004; 128:17-20)10.1016/j.jtcvs.2004.02.026
]Search in Google Scholar
[
4. Athanasuleas CL, Buckberg GD, Stanley AW, et al. for the RESTORE group. Surgical ventricular restoration in the treatment of congestive heart failure due to post- infarction ventricular dilatation. J Am Coll Cardiol, 2004; 44:1439-45.10.1016/j.jacc.2004.07.017
]Search in Google Scholar
[
5. Shah PJ, Hare DL, Raman JS et al. Survival after myocardial revascularisation for ischaemic cardiomyopathy: a prospective ten- year follow up study. J Thorac Cardiovasc Surg, 2003; 126:1320-1327.10.1016/S0022-5223(03)00809-2
]Search in Google Scholar
[
6. Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J Thorac Cardiovasc Surg, 2009 Nov;138(5):1060-1064.e2. doi: 10.1016/j.jtcvs.2009.07.015.10.1016/j.jtcvs.2009.07.01519837213
]Search in Google Scholar
[
7. Bonow RO, Castelvecchio S, Panza JA, et al. STICH Trial Investigators. Severity of remodelling, myocardial viability, and survival in ischemic LV Dysfunction after surgical revascularization. JACC Cardiovasc Imaging, 2015 Oct;8(10):1121-1129. doi: 10.1016/j.jcmg.2015.03.013.10.1016/j.jcmg.2015.03.013463301826363840
]Search in Google Scholar
[
8. Gheorghiade M, Sopko G, De Luca L et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation, 2006;114:1202-1213.10.1161/CIRCULATIONAHA.106.62319916966596
]Search in Google Scholar
[
9. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation, 1993 Jan;87(1):1-20. doi: 10.1161/01. cir.87.1.1. Erratum in: Circulation 1993 Jun;87(6):2070.10.1161/01.CIR.87.1.18418996
]Search in Google Scholar
[
10. Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischaemic left ventricular dysfunction. N Engl J Med 2011; 364:1617-2510.1056/NEJMoa1100358329090121463153
]Search in Google Scholar
[
11. Charaeonthaitawee P, Gersch BJ, Araoz PA, Gibbons RJ. Revascularisation in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol 2005; 46:567-74.10.1016/j.jacc.2005.03.07216098417
]Search in Google Scholar
[
12. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation, 1982 Sep;66(3):562-568. doi: 10.1161/01.cir.66.3.562.10.1161/01.CIR.66.3.562
]Search in Google Scholar
[
13. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation, 2003 Oct 21;108(16):1945-1953. doi: 10.1161/01.CIR.0000095029.57483.60.10.1161/01.CIR.0000095029.57483.6014557364
]Search in Google Scholar
[
14. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med, 1985 Jun 27;312(26):1665-71. doi: 10.1056/NEJM198506273122603.10.1056/NEJM1985062731226033873614
]Search in Google Scholar
[
15. Jolicoeur EM, Dunning A, Castelvecchio S, et al. Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. J Am Coll Cardiol 2015 Nov 10;66(19):2092-2100. doi: 10.1016/j. jacc.2015.08.882.
]Search in Google Scholar
[
16. Surruys PW, Morice MC Kappetein AP et al. for SYNTAX investigators. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease N Engl J Med 2009;360:961-972 (published correction appears in N Engl J Med 2013; 368-584.10.1056/NEJMoa080462619228612
]Search in Google Scholar
[
17. Ekman I, Cleland JG, Swedberg K et al. Symptoms in patients with heart failure are prognostic predictors. Insights from COMET. J Card Fail, 2005;11:288-292 [published corrections appear in J Card Fail 2005;11:404].10.1016/j.cardfail.2005.03.00715880338
]Search in Google Scholar
[
18. Mentz RJ, Fiuzat M, Shaw LK, et al. Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease). Am J Cardiol 2012 May 1;109(9):1272-7. doi: 10.1016/j.amjcard.2011.12.021.10.1016/j.amjcard.2011.12.02122325975
]Search in Google Scholar
[
19. Wrobel K, Stevens SR, Jones RH et al. Influence of baseline characteristics, operative conduct and postoperative cost on 30 days outcomes of coronary artery bypass grafting among patient with left ventricular dysfunction: results from the Surgical Treatment for Ischaemic heart failure (STICH) trial Circulation 2015;132:720-730.10.1161/CIRCULATIONAHA.114.014932
]Search in Google Scholar
[
20. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010 Sep;38 Suppl:S1- S52. doi: 10.1016/j.ejcts.2010.08.019.10.1016/j.ejcts.2010.08.01920850034
]Search in Google Scholar
[
21. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anaesthetists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58:e 123-210.
]Search in Google Scholar
[
22. Cleleand JG, Calvert M, Freemantle N, et al. The Heart Failure Revascularisation Trial (HEART) Eur J Failure 2011;13:227-33.10.1093/eurjhf/hfq230
]Search in Google Scholar
[
23. King College, London. Study of Efficacy and Safety of Percutaneous Coronary intervention to improve survival in heart failure (REVIVED – BRICS) 2015. Available at: http://clinicaltrials.gov/show/NTC01820048.
]Search in Google Scholar
[
24. Mancini GB, Hartigan PM, Shaw LJ, et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilising Revascularisation and Aggressive Drug Evaluation) coronary anatomy versus ischaemia. J Am Coll Cardiol Intv 2014;7:195-201.10.1016/j.jcin.2013.10.01724440015
]Search in Google Scholar
[
25. BARI 2D Study Group, Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009 Jun 11;360(24):2503-2515. doi: 10.1056/NEJMoa0805796.10.1056/NEJMoa0805796286399019502645
]Search in Google Scholar
[
26. Yamaguchi A, Ino T, Adachi H, et al. Left ventricular end-systolic volume index in patient with ischaemic cardiomyopathy predicts postoperative ventricular function. Ann Thor Surg 1995;60:1059-62.10.1016/0003-4975(95)00488-7
]Search in Google Scholar
[
27. Fang JC. Underestimating medical therapy for coronary disease... again. N Engl J Med 2011 Apr 28;364(17):1671-3. doi: 10.1056/NEJMe1103414.10.1056/NEJMe1103414
]Search in Google Scholar
[
28. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention patients with advanced left ventricular systolic dysfunction. Circulation 2006;113:230-7)10.1161/CIRCULATIONAHA.105.541664
]Search in Google Scholar
[
29. Windecker S, Koth P, Alfonso F et al 2014 ESC/EACTS guidelines of myocardial revascularisation. The Task Force of Myocardial Revascularisation of the European Society of Cardiology (ESC) and the European Assotiation of Cardiothoracic surgery (EACTS) Eur Heart J 2014;35:2541-619)10.1093/eurheartj/ehu278
]Search in Google Scholar
[
30. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002 Apr 3;39(7):1151-8. doi: 10.1016/s0735-1097(02)01726-6.10.1016/S0735-1097(02)01726-6
]Search in Google Scholar
[
31. Ramimstoola SH. Coronary bypass surgery for chronic angina ‒ 1981: a perspective. Circulation, 1982;65:225-41.10.1161/01.CIR.65.2.225
]Search in Google Scholar
[
32. Braunwald E, Rutherford JD. Reversible ischaemic left ventricular dysfunction. Evidence for “hibernating” myocardium. J Am Col Card 1986;8:1467-1470.10.1016/S0735-1097(86)80325-4
]Search in Google Scholar
[
33. Bounous EP, Mark DB, Pollock BG et al. Surgical survival benefits for contrary disease patients with left ventricular dysfunction. Circulation 1988;78:1151-1157.
]Search in Google Scholar
[
34. Auerbach MA, Schoder H, Hoh C et al Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999; 99:2921-2926.10.1161/01.CIR.99.22.2921
]Search in Google Scholar
[
35. Pitt B, Zanad F, Remm WJ et al. The effects of spironolactone on morbidity and mortality of patients with severe heart failure: Randomised Aldactone Evaluation Study Investigators N Engl J Med 1999;341:709-717.10.1056/NEJM199909023411001
]Search in Google Scholar
[
36. Uretsky BF, Thygesen K, Armstrong PW et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation, 2000;102:611-666.10.1161/01.CIR.102.6.611
]Search in Google Scholar
[
37. Di Carli MF, Davidson M, Little R et al. Value of Metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73: 527-533.10.1016/0002-9149(94)90327-1
]Search in Google Scholar
[
38. Baker DW, Jones R, Hodges J et al. Management of heart failure III. The role of revascularisation in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994; 272:1528-1534.10.1001/jama.1994.03520190074038
]Search in Google Scholar
[
39. Reimer KI, Murry CE, Yamasawa I et al. Four brief periods of myocardial ischaemia cause no cumulative ATP loss or necrosis. Am J Physio 1986 Dec;251(6 Pt 2):H1306-15. doi: 10.1152/ajpheart.1986.251.6.H1306.10.1152/ajpheart.1986.251.6.H13063789183
]Search in Google Scholar
[
40. Murry C, Jennings R, Reimer K. Studies from laboratories have shown that repeated brief interruption of the blood flow does not have cumulative deleterious effect. Circulation 1986, 74(5):1124-1136.10.1161/01.CIR.74.5.11243769170
]Search in Google Scholar
[
41. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979 Jun;40(6):633-44.
]Search in Google Scholar
[
42. Panza J, Velasques E, She L et al. Extent of coronary and myocardial disease and benefit from surgical revascularisation in ischemic LV dysfunction [corrected]. J Am Coll Cardiol, 2014;64:553-61.10.1016/j.jacc.2014.04.064412954725104523
]Search in Google Scholar
[
43. Geske J, Gersh B. Angina in revascularisation of ischemic cardiomyopathy. JACC 2015, 66(19):2101-2103.10.1016/j.jacc.2015.08.88026541920
]Search in Google Scholar
